Isis Pharma’s experimental blood thinner succeeds in mid-stage trial

MEDIC FINDER

(Reuters) ? Isis Pharmaceuticals Inc said its experimental blood thinner was more effective than a commonly prescribed anticoagulant in patients undergoing total knee replacement surgery.

The biotechnology company?s stock rose about 2.8 percent in light trading before the bell on…
Isis Pharma’s experimental blood thinner succeeds in mid-stage trial

View original post

Advertisements

www.arsalanaslam60.com

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s